Does anybody know if Allergan submitted its
Multifocal IOL to Medicare to be approved as a "newer
technology" IOL? This new catagory allows for higher
reimbursement from medicare compared to standard IOLs used for
cataract surgery. Starr Surgical (STAA) has already
submitted its Toric IOL for consideration.
Pyott wants to grow the company from within. They
already missed out on the excimer laser business. It
would have to be an RX with growth. Who did the sell
the MD Formulation to in the divestiture. What ever
happened to to Deucewood. Miss his comments and
Depth of Management could not handle a merger
at this time. Possibly the new CFO is reviewing
candidates. It would have to be small mainly a biotech who
could use the sales force.